class i phosphoinositide-3-kinase (Pi3K) isoforms generate the intracellular signaling lipid, phosphatidylinositol(3,4,5) trisphosphate (Ptdins(3,4,5)P 3 ). Ptdins(3,4,5)P 3 regulates major aspects of cellular behavior, and the use of both genetic and pharmacological intervention has revealed important isoform-specific roles for Pi3Ks in health and disease. despite this interest, current methods for measuring Ptdins(3,4,5)P 3 have major limitations, including insensitivity, reliance on radiolabeling, low throughput and an inability to resolve different fatty-acyl species. We introduce a methodology based on phosphate methylation coupled to high-performance liquid chromatography-mass spectrometry (hPlc-ms) to solve many of these problems and describe an integrated approach to quantify Ptdins(3,4,5)P 3 and related phosphoinositides (regio-isomers of PtdinsP and PtdinsP 2 are not resolved). this methodology can be used to quantify multiple fatty-acyl species of Ptdins(3,4,5)P 3 in unstimulated mouse and human cells (≥10 5 ) or tissues (≥0.1 mg) and their increase upon appropriate stimulation.
class i phosphoinositide-3-kinase (Pi3K) isoforms generate the intracellular signaling lipid, phosphatidylinositol(3,4,5) trisphosphate (Ptdins(3,4,5)P 3 ). Ptdins(3,4,5)P 3 regulates major aspects of cellular behavior, and the use of both genetic and pharmacological intervention has revealed important isoform-specific roles for Pi3Ks in health and disease. despite this interest, current methods for measuring Ptdins(3,4,5)P 3 have major limitations, including insensitivity, reliance on radiolabeling, low throughput and an inability to resolve different fatty-acyl species. We introduce a methodology based on phosphate methylation coupled to high-performance liquid chromatography-mass spectrometry (hPlc-ms) to solve many of these problems and describe an integrated approach to quantify Ptdins(3,4,5)P 3 and related phosphoinositides (regio-isomers of PtdinsP and PtdinsP 2 are not resolved). this methodology can be used to quantify multiple fatty-acyl species of Ptdins(3,4,5)P 3 in unstimulated mouse and human cells (≥10 5 ) or tissues (≥0.1 mg) and their increase upon appropriate stimulation.
Phosphoinositide-3-kinases (PI3Ks) phosphorylate one or more of the three canonical phosphoinositides that are found in all eukaryotic cells, PtdIns, PtdIns4P and PtdIns(4,5)P 2 , to form PtdIns3P, PtdIns(3,4)P 2 and PtdIns(3,4,5)P 3 , respectively. These lipid products are now recognized as pivotal intracellular signals that act by dictating the localization and activity of several key regulators of cellular function 1, 2 . The class I PI3Ks, of which there are four isoforms in mammalian cells (α, β, δ and γ), can be activated by many groups of cell-surface receptors to accelerate production of PtdIns(3,4,5)P 3 in the inner leaflet of the plasma membrane. A diverse family of proteins can selectively bind PtdIns(3,4,5)P 3 via their conserved pleckstrin homology (PH) domains, resulting in their activation and hence further translation and propagation of the original receptor signal.
Many cell processes are regulated by class I PI3Ks, including growth, survival and movement. Despite their common output signal, PtdIns(3,4,5)P 3 , the different class I PI3K isoforms perform different roles in both physiology and pathology 3 . This, combined with the 'drugability' of their active sites, has led to substantial investment in targeting the class I PI3Ks in a variety of disease settings, including PI3Kγ and PI3Kδ in inflammation and PI3Kα in oncology.
The amphiphilic phosphoinositides, including PtdIns(3,4,5)P 3 , have been quantified by several methods, which broadly showed that PtdIns(3,4,5)P 3 levels in unstimulated cells are 'very low' (typically undetectable) and rise fivefold to 50-fold upon stimulation to reach concentrations that are, at most, 10% of cellular PtdIns(4,5)P 2 amounts. These techniques are plagued by a variety of problems, including low sensitivity, sample through-put, dynamic range and applicability across a range of sample formats [4] [5] [6] . Further, as all phospholipids, phosphoinositides contain a wide range of potential constituent fatty-acid moieties and thus, in reality, comprise families of molecular species with a common headgroup. Classical chromatographic techniques and, more recently, mass spectrometry-based lipidomics approaches have been developed that can be used to resolve many families of fatty-acyl species, including those of the phosphoinositides 4, [7] [8] [9] [10] [11] [12] . PtdIns(3,4,5)P 3 , however, has proven very difficult to quantify using these approaches, primarily owing to problems with recovery, stability and yield of the relevant ions 7, 9, 13 .
These issues have hampered progress in understanding the class I PI3K signaling pathway. In particular, the inability to quantify the pathway's primary output signal is proving a major obstacle in developing an adequate, quantitative understanding of information flow through this pathway, including attempts to model the system. It has also hampered the development of biomarkers for reading out the impact of inhibitors of this pathway in vivo. This has lead to many workers using surrogate assays of pathway activity, such as phosphorylation levels of PKB, which are indirect and can be disconnected from PI3K signaling under some circumstances 14 . The inability to discriminate different fatty-acyl species of PtdIns(3,4,5)P 3 has also prevented any serious attempt to elucidate their functional importance.
We now present an integrated high-performance liquid chromatography-mass spectrometry (HPLC-MS)-based methodology that allows absolute and relative measurements of the concentration of PtdIns(3,4,5)P 3 and its different fatty-acyl species in small numbers of cells (≥10 5 ), either in suspension or adhered to tissue culture plates, and small samples of tissue. results establishing a quantitative assay for Ptdins(3,4,5)P 3 As part of our synthesis studies making phosphoinositides, we observed that precursor compounds whose phosphates were protected with benzyl groups, in contrast to their deprotected forms, gave good electrospray ionization mass spectra. We therefore reasoned that chemically protecting the acidic phosphate groups of PtdIns(3,4,5)P 3 in biological extracts using a mild and efficient method might offer a route to solving the major stability and sensitivity issues associated with its quantification by mass spectrometry.
We used trimethylsilyl diazomethane (TMS-diazomethane) because it enables relatively fast and clean esterification of protonated phosphate groups at room temperature 15 . Also, the solvent mixture into which PtdIns(3,4,5)P 3 is extracted from cells most efficiently (a mixture of chloroform, methanol and H 2 O with traces of HCl 16, 17 ) is an ideal environment for TMS-diazomethane reactions. Using TMS-diazomethane we achieved rapid and complete methylation of the phosphate groups in PtdIns(3,4,5)P 3 with some monomethylation of free hydroxyl groups in the inositol ring but no modification of unsaturated fatty acyl chains. The methylated PtdIns(3,4,5)P 3 species were more efficiently transferred into the mass spectrometer, with a reduced number of ionic species, compared to their underivatized counterparts, both simplifying and effectively sensitizing the mass spectrometry analysis.
We chromatographed derivatized lipid extracts through an inline C4 HPLC column before infusion into a triple quadrapole mass spectrometer in the positive-ion mode. This step concentrated the methylated PtdIns(3,4,5)P 3 species, but coelution with more abundant molecules necessitated a selective, second phase of mass fragmentation analysis (usually termed multiple reaction monitoring (MRM)). Molecular ions selected in the first quadrapole were fragmented in the second quadrapole using collision parameters optimized for cleavage between the phosphoinositide headgroup and the glycerol unit, yielding a charged fragment corresponding to the diacylglycerol and the neutral loss of a fragment corresponding to the methylated inositol phosphate headgroup (a neutral loss of 598 atomic mass units (amu)) for the major methylated species of PtdInsP 3 ; Supplementary Fig. 1 ). As the mass of the charged diacylglycerol fragments can be determined and the products of further fragmentation can also be analyzed, then, in the context of previous work, it is possible to assign the likely structure of the diacylglycerols and the parent lipids with some confidence. Also, although the focus of the study was on the measurement of PtdIns(3,4,5)P 3 , we could apply the same principle of 'measurement through neutral loss' to the measurement of other lipids that fragmented similarly, for example, measuring the diacylglycerol produced via loss of 490 amu for the methylated headgroup of PtdInsP 2 or 213 amu for the methylated headgroup of phosphatidylserine (PtdSer), providing useful parallel data.
First, we analyzed and quantified phosphoinositides in human neutrophils. We quenched control or formyl-Met-Leu-Phe (fMLP)-stimulated human neutrophils with chloroform, methanol and HCl to create a single-phase extract into which we spiked nonbiological 1-heptadecanoyl-2-palmitoyl-1-phosphatidylinositol 3,4,5-trisphosphate (C17:0/C16:0-PtdIns(3,4,5)P 3 ) as an internal standard. We extracted the samples, methylated them and infused into the mass spectrometer. We initially performed neutral loss scans on parent ions whose masses were in a range consistent with either potential esterified PtdInsP 2 or PtdIns(3,4,5)P 3 species, with the detector set to measure daughter ions (putative diacylglycerols) that were smaller by either 490 amu or 598 amu (see Supplementary Table 1 for a list of relevant structures and associated masses; sn-1/sn-2 assignment was based on biological precedent and further fragmentation of DAG species). This revealed two relatively abundant species of PtdInsP 2 (m/z of 1,095 and 1,117) in both control and stimulated cells (Fig. 1a,b) and two abundant species of PtdIns(3,4,5)P 3 (m/z of 1,203 and 1,225) that were more concentrated in the stimulated cells (Fig. 1c,d) (Fig. 1f) . The clarity with which fMLP increased the levels of the species quantified and the extent to which wortmannin, a selective PI3K inhibitor, prevented this increase provided biological confirmation that the assignment of ions to parental PtdIns(3,4,5)P 3 species was correct.
We refined our approach into a reliable and quantitative assay for targeted PtdIns(3,4,5)P 3 species. We found that synthetic internal standard or C18:0/C20:4-PtdIns(3,4,5)P 3 that had been spiked into primary neutrophil extracts, esterified and processed for mass spectrometry analysis was stable in mixtures of methanol:water (80%:20%) for ≥23 h at room temperature (18-25 °C) (Fig. 2a,b ) and could be detected in unstimulated extracts when as little as 0.25 ng had been added with excellent signal-to-noise ratio (Fig. 2c) . Both biological and synthetic PtdIns(3,4,5)P 3 species were routinely methylated to the same relative extent ( Supplementary Fig. 4 and Supplementary Table 2 ) and were detected with linear efficiency and sensitivity over at least a 0.5-20 ng range ( Fig. 2d and Supplementary Fig. 5 ). Addition of increasing amounts of synthetic C18:0/C20:4 PtdIns(4,5)P 2 to neutrophil extracts had no effect on the quantification of a parallel, internal spike of C18:0/C20:4-PtdIns(3,4,5)P 3 ( Supplementary  Fig. 6 ), showing the fidelity of the assay. If we spiked 10 ng of internal standard into primary extracts from different numbers of neutrophils, then there was a reduction in both its recovery and that of the endogenous PtdInsP 2 and PtdIns(3,4,5)P 3 with increasing cell number ( Supplementary Fig. 7 ). However, when we corrected the amount of the endogenous C18:0/C20:4-PtdInsP 2 or C18:0/C20:4-PtdIns(3,4,5)P 3 detected in these samples for the recovery of the internal standard, we observed a linear relationship between endogenous PtdInsP 2 or PtdIns(3,4,5)P 3 and cell number ( Fig. 2e and Supplementary Fig. 7 ).
These results indicate that the use of an internal, nonbiological standard, C17:0/C16:0-PtdIns(3,4,5)P 3 (internal standard), to correct for recovery through the extraction, methylation and mass spectrometry phases, is a very sensitive and robust method to measure the relative amounts of individual PtdIns(3,4,5)P 3 species in cells. Correction to the recovery of the internal standard also proved to be a good normalization factor for other lipids measured in parallel, typically up to 23 other lipids, including five different molecular species of PtdIns(3,4,5)P 3 and PtdInsP 2 from a single extract. We also noted that the ionizations of PtdIns(4,5)P 2 and PtdIns(3,4,5)P 3 in HPLC eluate were very similar, hence their ion currents were good indicators of their relative amounts (Fig. 2f) . A completely confident measure of the absolute amounts of a particular molecular species, however, requires the synthesis of the equivalent molecule to both calibrate the method and confirm the fragmentation analysis. We did this only for C18:0/C20:4-PtdIns(3,4,5)P 3 and C18:0/C20:4-PtdIns(4,5)P 2 .
Quantifying Ptdins(3,4,5)P 3 species in human neutrophils
We used this approach to measure changes in PtdInsP 2 and PtdIns(3,4,5)P 3 molecular species in human neutrophils stimulated with fMLP, a setting in which much previous work using other methods [18] [19] [20] [21] has given a clear benchmark. We found that fMLP stimulated a small, transient and parallel reduction in the amounts of both C18:0/C20:4-PtdInsP 2 and C18:0/C18:1-PtdInsP 2 (Fig. 3a) that is known to result from activation of PLCβ 22 and a parallel increase in C18:0/C20:4-PtdIns(3,4,5)P 3 and C18:0/C18:1-PtdIns(3,4,5)P 3 that is known to result from activation of PI3Kγ 23, 24 (Fig. 3b) These results suggest that the two common species of PtdInsP 2 and PtdIns(3,4,5)P 3 that we detected in human neutrophils, of which the C18:0/C20:4-containing molecules are the most abundant, are both available and recognized by the relevant PtdInsP 2 -and PtdIns(3,4,5)P 3 -metabolizing enzymes. However, a careful analysis of the conversion of each molecular species of PtdInsP 2 into its respective PtdIns(3,4,5)P 3 ( Fig. 3c) , indicated that C18:0/C20:4-PtdIns(3,4,5)P 3 accumulated selectively upon fMLP-stimulation (P < 0.0001, two-way ANOVA, factors being species and time for 6-120 s).
Quantifying Ptdins(3,4,5)P 3 species in mcF10a cells MCF10a cells are an immortalized human breast epithelial cell line that has been used to create homologously targeted variants relevant to the study of PI3K signaling pathways 25, 26 , including deletion of the PtdIns(3,4,5)P 3 3-phosphatase PTEN. These cells are highly adherent, and hence we first adapted the extraction protocol to avoid the need for chloroform contact with the tissue culture plastic, and then attempted to detect PtdInsP 2 and PtdIns(3,4,5)P 3 molecular species. Neutral loss scans revealed five common fattyacyl species of both PtdInsP 2 and PtdIns(3,4,5)P 3 ( Fig. 4a,b ; details of molecular species and masses of respective parent ions detected in MCF10a cells are available in Supplementary Table 1 ; we also detected these species in neutral loss scans of PtdInsP and PtdIns (data not shown)). We quantified these five species in extracts from 10 5 growing, starved or starved then EGF-stimulated wildtype or PTEN −/− MCF10a cells (Fig. 4c,d) . We determined the efficiency of the extraction process using an internal spike of internal standard and corrected variations in cell input using the quantity of methylated C18:0/C18:1-PtdSer we recovered from the same extracts. In a small number of parallel assays we also quantified phosphoinositide pools in these cells using conventional [ 3 H]myo-inositol labeling and quantification of deacylated phosphoinositides by anion-exchange HPLC. The relative sizes of the total PtdInsP 2 and PtdIns(3,4,5)P 3 pools derived using either assay format were remarkably similar and exhibited similar changes upon EGF stimulation (Supplementary Fig. 8 ), supporting the fidelity of the mass spectrometric analysis.
The concentrations of all five species of PtdIns(3,4,5)P 3 were increased by EGF-stimulation in a manner augmented by loss of PTEN (Fig. 4d) . Although C18:0/C20:4-PtdInsP 2 was the least abundant species of PtdInsP 2 , this fatty-acyl species accumulated selectively in the PtdIns(3,4,5)P 3 pool upon EGF stimulation ( Fig. 4e ; P < 0.0001, two-way ANOVA, factors being species and conditions).
Quantifying Ptdins(3,4,5)P 3 species in fat and liver Quantification of PtdIns(3,4,5)P 3 in small samples of tissue remains an academically and commercially important challenge. We used our approach to measure class I PI3K activity in vivo by studying the effects of insulin on mouse liver and human fat.
We injected mice of either wild-type or Gnasxl m+/p− genetic background (Gnasxl m+/p− mice lack XLαS, the imprinted isoform of Gαs, and are hypersensitive to insulin 27 ) intraperitoneally with insulin or a saline control and 8 min later rapidly froze samples of liver. We spiked primary lipid extracts with internal standard and then processed them as described. Neutral loss scans revealed that C18:0/C20:4 molecular species were by far the most abundant versions of both PtdInsP 2 and PtdIns(3,4,5)P 3 in these samples ( Fig. 5a and Supplementary Fig. 9 ). We then quantified C18:0/C20:4-PtdIns(3,4,5)P 3 and other phosphoinositides as described above using C18:0/C20:4-PtdSer to correct for sample size. In parallel, we prepared SDS lysates from the same frozen specimens to quantify phosphorylation of PKB, as a known marker of PI3K activation. Insulin stimulated a substantial increase in the amounts of C18:0/C20:4-PtdIns(3,4,5)P 3 that was augmented in the Gnasxl m+/p− genetic background ( Fig. 5b) but had no effect on the amounts of C18:0/C20:4-PtdInsP 2 ( Supplementary Fig. 9 ). Insulin also increased phosphorylation of PKB in the liver samples, although this response appeared less strongly augmented in the Gnasxl m+/p− genetic background ( Fig. 5c and Supplementary Fig. 10 ). Human adipose tissue is highly responsive to changes in blood insulin. We starved healthy human individuals overnight and removed and froze small biopsies of adipose tissue both before and 90 min after oral ingestion of glucose. We made a minor modification to our standard extraction procedure to predeplete the neutral storage lipids before extracting the polyphosphoinositides. This had no effect on recovery of internal standard or endogenous PtdInsP 2 and PtdIns(3,4,5)P 3 species but reduced recovery of less polar lipids such as PtdIns and PtdSer. Neutral loss scans revealed that the main molecular species of both PtdInsP 2 and PtdIns(3,4,5)P 3 was C18:0/C20:4 ( Fig. 5d and Supplementary  Fig. 9 ). We quantified C18:0/C20:4-PtdIns(3,4,5)P 3 as above but using PtdInsP 2 to correct for the amount of tissue (because recovery of PtdSer was poor under the modified conditions). In parallel, we prepared SDS lysates and quantified phosphorylation of PKB; the amounts of C18:0/C20:4-PtdIns(3,4,5)P 3 increased after glucose ingestion, and this was paralleled by an increase in PKB phosphorylation (Fig. 5e,f and Supplementary Figs. 9 and 10) . discussion As PtdIns(3,4,5)P 3 is the sole PtdInsP 3 in cells it can be quantified directly by our approach without the need for additional purification from other regioisomers before infusion into a mass spectrometer. In principle, this approach could be extended to the quantification of other phosphoinositides if it could be coupled to a method that could distinguish between positional isomers on the inositol ring, for example, distinguishing between the three biological isomers of PtdInsP 2 (PtdIns(4,5)P 2 , PtdIns(3,5)P 2 and PtdIns(3,4)P 2 ) or PtdInsP (PtdIns3P, PtdIns4P and PtdIns5P).
In addition to providing a sensitive and reproducible route to quantifying PtdIns(3,4,5)P 3 and related phosphoinositides, the methodology described here also can be used to identify the fatty acyl complement of the molecular species measured. In all of the primary cells and tissues that we investigated, the most abundant species of PtdIns(3,4,5)P 3 , PtdInsP 2 , PtdInsP and PtdIns was, by far, the stearoyl/arachidonoyl form. This is consistent with much previous work indicating arachidonate is highly and selectively enriched in the sn-2 position of phosphoinositides 7, 9, 12 . The notable exception was MCF10a cells, in which the stearoyl/arachidonoyl species of these lipids were among the least prevalent. Others have reported that cell lines grown in the presence of serum become "deficient" in arachidonate 28 , potentially explaining this observation. However, we observed that the stearoyl/arachidonoyl form of PtdIns(3,4,5)P 3 selectively accumulated in both EGF-stimulated MCF10a cells and fMLP-stimulated neutrophils relative to its levels of enrichment in the total cell pool of its precursor, PtdInsP 2 . This suggests mechanisms must exist to selectively accumulate the stearoyl/arachidonoyl form of PtdIns(3,4,5)P 3 in stimulated cells, raising important questions as to how this occurs and why. [ 3 H]inositol was from PerkinElmer. All cell culture reagents were from Invitrogen unless specified. All other reagents, unless specified, were from Sigma. All lipid extractions used 2 ml polypropylene safe-lock tubes (Eppendorf).
Stock solutions for lipid extractions.
Before to extraction, the following solutions were prepared using standard glassware; the quench mixture comprising 484 ml MeOH, 242 ml CHCl 3 and 23.55 ml 1 M HCl; the pre-derivization wash composed of 240 ml CHCl 3 , 120 ml MeOH and 90 ml 0.01 M HCl; and the post-derivatization wash made up of 240 ml CHCl 3 , 120 ml MeOH and 90 ml H 2 O. Wash mixtures were shaken and allowed to separate into two phases. The upper phase of each solution was used.
Preparation of human neutrophils. We isolated human neutrophils from the peripheral blood of healthy volunteers with written consent (Research Ethics Committee approval number 06/Q0108/165) as described previously 30 . Purity was determined by cytospin and REASTAIN Quick-Diff (Reagena) staining, and was at least 95%. After washing, we resuspended neutrophils in Dulbecco's PBS with Ca 2+ and Mg 2+ , 1g l −1 glucose and 4 mM sodium bicarbonate (DPBS+) at 3 × 10 7 cells ml −1 .
Where appropriate, we stimulated 170-µl aliquots of cells with 100 nM fMLP for indicated times at 37 °C, terminated reactions by addition of quench mix (750 µl) and extracted and processed lipids as described below. Where appropriate, we pretreated cells with 300 nM of the PI3K inhibitor wortmannin for 10 min at 37 °C, before stimulation.
Preparation of MCF10a cells. PTEN +/+ and PTEN −/− MCF10a
were provided by Horizon Discovery and maintained at 37 °C, 5% CO 2 , in DMEM/F12 medium (Invitrogen), supplemented with horse serum (5%, PAA), hydrocortisone (0.5 µg ml −1 ), insulin (10 µg ml −1 ), cholera toxin (0.1 µg ml −1 ) and EGF (2 ng ml −1 ). When required, we starved cells in DMEM/F12 medium supplemented with charcoal-stripped horse serum (1%, PAA) hydrocortisone and cholera toxin. Early passages of cells were used (passages [13] [14] [15] 4 .6 µM final concentration in the medium). We starved cells for 17 h, and then stimulated them with 2 ng ml −1 EGF for 2 min at 37 °C. Both [ 3 H]inositol-labeled and -unlabeled cells were processed as described above, and extracted identically to the point before derivatization, where labeled cells were deacylated, extracted and separated by HPLC as described previously 6 .
Preparation of liver samples. All mice were housed in the small animal barrier unit (SABU) at the Babraham Institute under specific pathogen-free conditions. We injected wild-type and Gnasxl m+/p− mice 27 that fasted overnight for 16 h, intraperitonally with saline or insulin (10 U kg −1 body weight). We collected livers 8 min after injection, rinsed them rapidly in cold PBS and immediately froze them in liquid N 2 . Frozen livers were stored at -80 °C until use. This work was performed on Home Office Project License PPL 80/2364.
For lipid extraction, we homogenized portions of frozen liver (3-4 mg) in a Dounce homogenizer with quench mix (1 ml). We collected the homogenate, then added another aliquot of quench mix (1 ml) to the homogenizer and, after rinsing, this was removed and pooled with the first homogenate (total 2 ml). We diluted the final combined homogenates 1:5 with quench mix, and two aliquots (750 µl) were taken. We added H 2 O (170 µl) to each aliquot, and then we extracted and processed these samples in parallel, as described below.
Preparation of adipose samples. Healthy human individuals (volunteers, from whom informed written consent was obtained) fasted overnight and needle biopsies of abdominal, subcutaneous, adipose tissue were taken after infiltrating the tissue with 1% lignocaine. We took biopsies before and 90 min after oral ingestion of 75 g of glucose. We immediately rinsed biopsies in saline, then snap-froze them in liquid N 2 . For analysis, we ground the frozen adipose to a fine powder with a mortar and pestle under liquid N 2 . We homogenized aliquots of the frozen material (~15 mg) in a Dounce homogenizer with CHCl 3 -methanol (1:2, v:v, 1 ml) and washed through with another wash (1 ml). Duplicate aliquots (725 µl) underwent additional processing before standard extraction and processing of polar lipids, to remove neutral lipids, as described below.
Lipid extraction. We created primary lipid extracts from neutrophils, MCF10a cells or liver samples, as described above. This resulted in a thoroughly mixed, single-phase sample (from 170 µl of aqueous sample and 750 µl of quench mix) in a safe-lock polypropylene tube (2 ml). We then added an aliquot of ISD (10 µl containing 1 ng C17:0/C16:0 PtdIns(3,4,5)P 3 ISD), vortexed and allowed the sample to stand for another 5 min at room temperature (18-25 °C) . We then added CHCl 3 (725 µl) and 2 M HCl (170 µl), mixed the sample thoroughly again and centrifuged in a bench-top microcentrifuge (1,500g, 5 min at room temperature).
This created a two-phase system with an upper aqueous layer and a protein band at the interface. We collected the lower organic phase into a fresh tube and then added prederivatization wash (708 µl). We then vortexed briefly, centrifuged in a microcentrifuge (1,500g, 3 min at room temperature) and collected the lower phase into another fresh tube for derivatization.
We removed neutral lipids from adipose homogenates by first adding H 2 O (170 µl) and 50 mM LiOH (25 µl) to a 725 µl aliquot of adipose homogenate in CHCl 3 /MeOH (1:2, v:v) and then mixing the sample thoroughly. We added 1 ng ISD, mixed and then added CHCl 3 (725 µl). We mixed the sample again, centrifuged (1,500g, 5 min at room temperature) and then removed the resultant lower phase (containing neutral lipids). We repeated the CHCl 3 wash step and added CHCl 3 -methanol (500 µl, 2:1, v/v), 2 M HCl (170 µl) and and CHCl 3 (500 µl) to the retained upper phase, vortexed thoroughly and then allowed the sample to stand for 5 min at room temperature. We centrifuged the sample (1,500g, 5 min at room temperature) and then collected the lower organic phase into a fresh tube. We added 708 µl of prederivatization wash, mixed and centrifuged to separate the phases. We then collected the resultant lower phase into a fresh tube before derivatization.
Derivatization. Note that trimethylsilyl diazomethane (International Union of Pure and Applied Chemistry (IUPAC) name (diazomethyl)trimethylsilane; abbreviated here TMSdiazomethane) is toxic by inhalation, producing central nervous system depression, drowsiness, dizziness and lung damage. Although it is not currently considered an explosive risk and it is certainly less dangerous from this perspective than diazomethane, we would still advocate taking appropriate precautions and treat it as though it is. We routinely destroy excess reagent with care in 10% acetic acid in methanol solutions and rinse and immerse all syringes and glassware that might contain TMS-diazomethane in this solution. Be aware that when TMS-diazomethane is neutralized with acetic acid, nitrogen gas is evolved and it is a violent reaction, so if large volumes are being destroyed great care should be exercised. We advocate only using this reagent in a fume hood with adequate personal safety equipment and that only people who have read the manufacturers safety data sheets and fully understand the risks carry out this reaction. We always do this reaction in the presence of a qualified chemist who can ensure that all appropriate safety measures are taken.
We added 2 M TMS-diazomethane in hexane (50 µl) to lipid extracts prepared as described above (~1 ml of 'lower phase'), to give a yellow solution, and then allowed the reaction to proceed for 10 min at room temperature. We quenched reactions with glacial acetic acid (6 µl), which removed the sample's yellow color (this reaction releases N 2 gas, thus care should be taken). We added post-derivatization wash solution (700 µl) to the organic solution, and mixed the samples, which we then centrifuged (1,500g, 3 min), and collected the resultant lower phase. We repeated the wash step, and then added MeOH:H 2 O (9:1 v:v, 100 µl) to the final collected lower phase. We dried samples under a stream of N 2 at room temperature until almost dry (about 10 µl remaining). We immediately dissolved samples in MeOH (80 µl), sonicated briefly, and added H 2 O (20 µl). We subjected final samples to mass spectrometer analysis as described below.
Mass spectrometry analysis. Analysis of lipid profiles from neutrophil extracts (Figs. 1a-d, 2a-e and 3 and Supplementary  Figs. 2e,f, 3e,f, 5 and 7 ) was performed on a Quattro Ultima mass spectrometer (Waters), connected to a Waters 2795 HPLC system. We used 90 µl sample injections. A 67% to 90% acetonitrile in water gradient over 20 min containing 0.1% trifluoroacetic acid (TFA) was used for separation on a 1 mm × 50 mm Jupiter C4 column from Phenomenex. Full details of these and other parameters for the Quattro Ultima mass spectrometer are available in Supplementary Data 1.
All other samples (Figs. 1e,f, 2f, 5 and 6 , and Supplementary  Figs. 2a-d, 3a-d, 4 and 8) were analyzed using a ABSciex QTRAP 4000 connected to a Waters Acquity UPLC system, with duplicate 45-µl samples injected. A 45% to 100% acetonitrile in water gradient over 15 min containing 0.1% formic acid was used with a Waters Acquity UPLC BEH 300 C4 1.7 µm, 1 mm × 100 mm column. Full details of these and other parameters for the QTRAP mass spectrometer are available in Supplementary Data 2.
Integrated area of lipid species peaks were corrected for recovery against ISD area (giving a response ratio for each lipid) and then, to account for cell number, normalised to PtdSer, also corrected to internal standard (C18:0/C20:4 PtdSer for liver, C18:0/C18:1 PtdSer for MCF10a cells; response ratios were linear with cell number).
Phospho-PKB western blot analysis. We resuspended frozen liver (50 mg) or adipose (5 mg) samples that had been crushed to a fine powder in a mortar and pestle, in cold lysis buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.1% Triton supplemented with 2.5 mM sodium pyrophosphate, 5 mM β-glycerol phosphate, 1 mM sodium orthovanadate, 1 mM sodium fluoride, 0.1 mM PMSF and 10 µg ml −1 of anti-proteases leupeptin, aprotinin, antipain and pepstatin A). We allowed samples to lyse for 30 min at 4 °C with end-on-end rotation. We removed insoluble material by centrifugation (15,000g, 15 min, 4 °C), and quantified protein in the resultant supernatant by Bradford Protein Assay (Bio-Rad), before diluting in SDS-sample buffer. We separated proteins from 50 µg (liver) or 7.5 µg (adipose) samples by SDS-PAGE and transferred to PVDF membrane. We blotted samples for phosphoPKB and loading controls (actin, β-COP), using primary antibodies to phosphoPKB ser473(DE9) (rabbit, Cell Signaling 4060, 1:2,000), actin (Sigma A3853, mouse, 1:10,000) and β-COP (from N. Ktistakis, Babraham Institute, mouse, 1:200) in TBS/0.1% Tween, 5% BSA, 2 h at room temperature; and secondary IgG antibodies InfraRedDye 680 goat α-rabbit (926-32221, LI-COR), and 800CW goat α-mouse (926-32210 LI-COR), 1:10,000 for 1 h in the dark. Fluorescence was detected and quantitated with an Odyssey Imaging System (LI-COR) with Phospho-PKB signal corrected for loading controls.
Statistics.
A two-way ANOVA was used to analyze the data shown in Figure 3 . The factors we isolated were time and species, and we analyzed all of the data except that for the unstimulated (0 min) controls. A two-way ANOVA was used to analyze the data presented in Figure 4 . The factors we isolated were the different molecular species and the conditions (that is, wild type, PTEN −/− , growth medium, starved and EGF-stimulated). We looked for differences between log 2 ratios among species,
